Zdrowie i gospodarka · 12/05/2021

FDA Releases Final Guidance on Reproductive and Developmental Toxicity for Human Pharmaceuticals

The FDA has released a final guidance for industry on detecting reproductive and developmental toxicity in human pharmaceuticals, developed in collaboration with the International Council for Harmonisation, to help companies design studies and assess risks.